Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures

Colorectal cancer (CRC) is one of the most common cancers, and it frequently metastasizes to the liver and lymph nodes. Despite major advances in treatment modalities, CRC remains a poorly characterized biological malignancy, with high reported cases of deaths globally. Moreover, cancer stem cells (...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokgautsi, Ntlotlang, Kuo, Yu-Cheng, Huang, Yan-Jiun, Chen, Chien-Hsin, Mukhopadhyay, Debabrata, Wu, Alexander T. H., Huang, Hsu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856425/
https://www.ncbi.nlm.nih.gov/pubmed/36672201
http://dx.doi.org/10.3390/cells12020266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856425/
https://www.ncbi.nlm.nih.gov/pubmed/36672201
http://dx.doi.org/10.3390/cells12020266

Ejemplares similares